KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Short term Debt (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Short term Debt data on record, last reported at $75.0 million in Q4 2025.

  • For Q4 2025, Short term Debt fell 70.0% year-over-year to $75.0 million; the TTM value through Dec 2025 reached $75.0 million, down 70.0%, while the annual FY2025 figure was $75.0 million, 70.0% down from the prior year.
  • Short term Debt reached $75.0 million in Q4 2025 per IDXX's latest filing, down from $150.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $611.0 million in Q2 2022 and bottomed at $75.0 million in Q3 2021.
  • Average Short term Debt over 5 years is $173.9 million, with a median of $137.5 million recorded in 2021.
  • Peak YoY movement for Short term Debt: crashed 74.33% in 2021, then soared 388.87% in 2022.
  • A 5-year view of Short term Debt shows it stood at $75.0 million in 2021, then soared by 233.35% to $250.0 million in 2022, then crashed by 70.0% to $75.0 million in 2023, then surged by 233.35% to $250.0 million in 2024, then tumbled by 70.0% to $75.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $75.0 million in Q4 2025, $150.0 million in Q3 2025, and $75.0 million in Q2 2025.